![Alexander Schmitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Schmitz
Directeur/Membre du Conseil chez
VentureMed Group, Inc.
Profil
Alexander Schmitz is currently a Director at Relievant Medsystems, Inc., Vertiflex, Inc., Lumeon Ltd., Nalu Medical, Inc., VentureMed Group, Inc., and Lumeon, Inc. He started his position as a Director at Lumeon Ltd. and Nalu Medical, Inc. in 2020.
Prior to his current roles, he was a Partner at Endeavour Vision SA starting in 2015.
Mr. Schmitz has also held former positions as an Independent Director at Rapid Micro Biosystems, Inc. from 2020 to 2022, a Director at Nuvaira, Inc. and EndoStim, Inc., and as a Vice President-Business Development at Biosensors International Group Ltd. from 2005 to 2014.
He holds an MBA from INSEAD and an undergraduate degree from Georgetown University.
Postes actifs de Alexander Schmitz
| Sociétés | Poste | Début |
|---|---|---|
Endeavour Vision SA
 Endeavour Vision SA Investment ManagersFinance EV develops a long-term investment strategy with their entrepreneurs. Their investment objective is to grow firms and to create a market leader in a new field. They focus on developing businesses active in industries including information technology, biotech, medtech and cleantech. They concentrate on various stages such as early to expansion-stage as well as spin-offs and restarts. Their geographic focus is pan-European. Specifically, their technology-sector investments are concentrated in Norway, Sweden, Finland, UK, Ireland, Germany, Switzerland, France, Italy and Portugal. Beyond these countries, they also consider taking a co-lead or a syndicate role. For their life sciences investments, they primarily target Switzerland, France and Germany. Four key investment criteria they consider before investment are hyper-growth market potential, world-class technology, capital efficiency and ambitious management team. EV's preferred role is to be lead investor or possibly co-lead. They also consider being syndicate partner on some occasions. EV's investment horizon is generally 10 years, with that timeframe extended for firms in hyper-growth stage. On average, their investments typically take five years to mature. The majority of their exits are through a listing in one of the main markets while many of the VC-backed firms are acquired. | Private Equity Investor | 01/01/2015 |
VentureMed Group, Inc.
 VentureMed Group, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales medical devices | Directeur/Membre du Conseil | - |
Vertiflex, Inc.
 Vertiflex, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company | Directeur/Membre du Conseil | - |
Nalu Medical, Inc.
 Nalu Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to manage intractable chronic pain | Directeur/Membre du Conseil | 01/07/2020 |
Relievant Medsystems, Inc.
 Relievant Medsystems, Inc. Medical SpecialtiesHealth Technology Develops intraosseous nerve ablation systems to treat chronic back pain | Directeur/Membre du Conseil | - |
Lumeon Ltd.
 Lumeon Ltd. Information Technology ServicesTechnology Services Operates as a digital health company that provides clinical automation services | Directeur/Membre du Conseil | 08/07/2020 |
Lumeon, Inc.
 Lumeon, Inc. Packaged SoftwareTechnology Services Operates as a digital healthcare firm that provides organizations mend broken care coordination processes through automated care orchestration | Directeur/Membre du Conseil | - |
Anciens postes connus de Alexander Schmitz
| Sociétés | Poste | Fin |
|---|---|---|
| RAPID MICRO BIOSYSTEMS, INC. | Directeur/Membre du Conseil | 23/05/2022 |
| BIOSENSORS INTERNATIONAL GROUP LTD | Corporate Officer/Principal | 01/01/2014 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Alexander Schmitz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Biosensors International Group Ltd.
 Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes medical devices for heart surgery and intensive care treatment | Health Technology |
Relievant Medsystems, Inc.
Relievant Medsystems, Inc. Medical SpecialtiesHealth Technology Develops intraosseous nerve ablation systems to treat chronic back pain | Health Technology |
Rapid Micro Biosystems, Inc.
 Rapid Micro Biosystems, Inc. Industrial MachineryProducer Manufacturing Develops automation solutions for pharmaceutical and healthcare manufacturing products | Producer Manufacturing |
Vertiflex, Inc.
Vertiflex, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
Nuvaira, Inc.
 Nuvaira, Inc. Medical SpecialtiesHealth Technology Develops medical devices for treating lung diseases | Health Technology |
EndoStim, Inc.
 EndoStim, Inc. Medical SpecialtiesHealth Technology Develops electro medical devices to treat gastrointestinal neuromuscular disorders | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endeavour Vision SA
Endeavour Vision SA Investment ManagersFinance EV develops a long-term investment strategy with their entrepreneurs. Their investment objective is to grow firms and to create a market leader in a new field. They focus on developing businesses active in industries including information technology, biotech, medtech and cleantech. They concentrate on various stages such as early to expansion-stage as well as spin-offs and restarts. Their geographic focus is pan-European. Specifically, their technology-sector investments are concentrated in Norway, Sweden, Finland, UK, Ireland, Germany, Switzerland, France, Italy and Portugal. Beyond these countries, they also consider taking a co-lead or a syndicate role. For their life sciences investments, they primarily target Switzerland, France and Germany. Four key investment criteria they consider before investment are hyper-growth market potential, world-class technology, capital efficiency and ambitious management team. EV's preferred role is to be lead investor or possibly co-lead. They also consider being syndicate partner on some occasions. EV's investment horizon is generally 10 years, with that timeframe extended for firms in hyper-growth stage. On average, their investments typically take five years to mature. The majority of their exits are through a listing in one of the main markets while many of the VC-backed firms are acquired. | Finance |
Lumeon Ltd.
Lumeon Ltd. Information Technology ServicesTechnology Services Operates as a digital health company that provides clinical automation services | Technology Services |
Nalu Medical, Inc.
Nalu Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to manage intractable chronic pain | Health Technology |
VentureMed Group, Inc.
VentureMed Group, Inc. Medical SpecialtiesHealth Technology Manufactures and wholesales medical devices | Health Technology |
Lumeon, Inc.
Lumeon, Inc. Packaged SoftwareTechnology Services Operates as a digital healthcare firm that provides organizations mend broken care coordination processes through automated care orchestration | Technology Services |
